86 related articles for article (PubMed ID: 16518477)
21. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
22. The normal counterpart to the chronic lymphocytic leukemia B cell.
Caligaris-Cappio F; Ghia P
Best Pract Res Clin Haematol; 2007 Sep; 20(3):385-97. PubMed ID: 17707828
[TBL] [Abstract][Full Text] [Related]
23. Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70.
Secchiero P; di Iasio MG; Gonelli A; Barbarotto E; Melloni E; Tiribelli M; Chiaruttini C; Zauli G
J Cell Physiol; 2007 Oct; 213(1):229-36. PubMed ID: 17476690
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors.
Tavolaro S; Chiaretti S; Messina M; Peragine N; Del Giudice I; Marinelli M; Santangelo S; Mauro FR; Guarini A; Foà R
Leuk Res; 2010 Jun; 34(6):733-41. PubMed ID: 20036005
[TBL] [Abstract][Full Text] [Related]
25. The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia.
Kipps TJ
Best Pract Res Clin Haematol; 2007 Sep; 20(3):415-24. PubMed ID: 17707830
[TBL] [Abstract][Full Text] [Related]
26. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
27. c-Abl expression in chronic lymphocytic leukemia cells: clinical and therapeutic implications.
Lin K; Glenn MA; Harris RJ; Duckworth AD; Dennett S; Cawley JC; Zuzel M; Slupsky JR
Cancer Res; 2006 Aug; 66(15):7801-9. PubMed ID: 16885384
[TBL] [Abstract][Full Text] [Related]
28. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.
Kharfan-Dabaja MA; Chavez JC; Khorfan KA; Pinilla-Ibarz J
Cancer; 2008 Sep; 113(5):897-906. PubMed ID: 18618518
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypic characterization of IgVH3-72 B-cell chronic lymphocytic leukaemia (B-CLL).
Capello D; Zucchetto A; Degan M; Bomben R; Dal Bo M; Efremov DG; Laurenti L; Del Poeta G; Gaidano G; Gattei V
Leuk Res; 2006 Sep; 30(9):1197-9. PubMed ID: 16417919
[TBL] [Abstract][Full Text] [Related]
30. Igbeta(CD79b) mRNA expression in chronic lymphocytic leukaemia cells correlates with immunoglobulin heavy chain gene mutational status but does not serve as an independent predictor of clinical severity.
Cajiao I; Sargent R; Elstrom R; Cooke NE; Bagg A; Liebhaber SA
Am J Hematol; 2007 Aug; 82(8):712-20. PubMed ID: 17315213
[TBL] [Abstract][Full Text] [Related]
31. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression.
Deglesne PA; Chevallier N; Letestu R; Baran-Marszak F; Beitar T; Salanoubat C; Sanhes L; Nataf J; Roger C; Varin-Blank N; Ajchenbaum-Cymbalista F
Cancer Res; 2006 Jul; 66(14):7158-66. PubMed ID: 16849562
[TBL] [Abstract][Full Text] [Related]
32. ZAP-70 mRNA expression provides clinically valuable information in early-stage chronic lymphocytic leukemia.
Reinoso-Martín C; Jantus-Lewintre E; Ballesteros CG; Campos CB; Ferrer JR; García-Conde J
Haematologica; 2008 Sep; 93(9):1422-4. PubMed ID: 18757853
[No Abstract] [Full Text] [Related]
33. MicroRNA in chronic lymphocytic leukemia.
Chng WJ
N Engl J Med; 2006 Feb; 354(5):524-5; author reply 524-5. PubMed ID: 16456940
[No Abstract] [Full Text] [Related]
34. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL).
Richardson SJ; Matthews C; Catherwood MA; Alexander HD; Carey BS; Farrugia J; Gardiner A; Mould S; Oscier D; Copplestone JA; Prentice AG
Blood; 2006 May; 107(9):3584-92. PubMed ID: 16332969
[TBL] [Abstract][Full Text] [Related]
35. Differential expression and function of CD27 in chronic lymphocytic leukemia cells expressing ZAP-70.
Lafarge ST; Hou S; Pauls SD; Johnston JB; Gibson SB; Marshall AJ
Leuk Res; 2015 Jul; 39(7):773-8. PubMed ID: 26002513
[TBL] [Abstract][Full Text] [Related]
36. [ZAP-70--a marker in chronic B-cell lymphocytic leukemia].
Bogdanov AN; Krivolanov IuA; Zaĭtsev KA; Kamilova TA
Vopr Onkol; 2008; 54(1):7-18. PubMed ID: 18416051
[No Abstract] [Full Text] [Related]
37. Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia.
Rees-Unwin KS; Faragher R; Unwin RD; Adams J; Brown PJ; Buckle AM; Pettitt A; Hutchinson CV; Johnson SM; Pulford K; Banham AH; Whetton AD; Lucas G; Mason DY; Burthem J
Br J Haematol; 2010 Feb; 148(4):534-43. PubMed ID: 19961478
[TBL] [Abstract][Full Text] [Related]
38. Is the c-Cbl proto-oncogene involved in chronic lymphocytic leukemia?
Mankaï A; Eveillard JR; Buhé V; Le Ster K; Loisel S; Ghedira I; Youinou P; Berthou C; Bordron A
Ann N Y Acad Sci; 2007 Jun; 1107():193-205. PubMed ID: 17804547
[TBL] [Abstract][Full Text] [Related]
39. ZAP-70 expression remains stable in chronic lymphocytic leukaemia.
Gibbs G; Bromidge T; Howe D; Johnson S
Int J Lab Hematol; 2007 Jun; 29(3):225-7. PubMed ID: 17474902
[No Abstract] [Full Text] [Related]
40. Expression of ZAP-70 in patients with chronic lymphocytic leukemia may change significantly during the course of the disease.
Smolej L; Vroblova V; Novosad J
Int J Lab Hematol; 2008 Jun; 30(3):259-60; author reply 260. PubMed ID: 18479306
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
